Heart News and Research

RSS

Loyola receives $60,666 American Heart Association grant for cardiac research

The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $60,666 for cardiac research in 2012, bringing the lifetime total the AHA has awarded to Loyola to more than $10 million.

29 Nov 2012

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

29 Nov 2012

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.

29 Nov 2012

IL17RC-mediated immune responses can be crucial in causing AMD

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.

29 Nov 2012

$ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction$

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so called HFPEF - a type of heart failure that until now has been impossible to treat.

29 Nov 2012

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

It is likely that there is more than one reason why people with cancer experience fatigue. The causes are likely to include side effects of the treatment that people are receiving for cancer as well as the direct effects of the cancer.

28 Nov 2012

Digoxin for atrial fibrillation questioned

Experts are calling into question the widespread use of digoxin for atrial fibrillation, in the wake of findings linking the drug to increased mortality.

28 Nov 2012

Combination of mixed amphetamine salts and topiramate shows promise for cocaine dependence

Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and the tendency of cocaine to attract people who make poor life choices and then exacerbate impulsive behavior all make cocaine a vexing clinical condition.

28 Nov 2012

Diptheria-tetanus-pertussis vaccine: an interview with Dr. Rudi Eggers, World Health Organisation

The Diptheria-tetanus-pertussis vaccine is sometimes also called the “triple vaccine” and has been around for about 50 years, and it protects against diphtheria, tetanus, and pertussis. These are serious diseases caused by bacteria.

28 Nov 2012

Digoxin increases risk of death in patients with atrial fibrillation

Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.

28 Nov 2012

Intramyocardial injection of organ-derived stem cells after AMI improves left ventricle function

A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.

28 Nov 2012

New investigational procedure may prolong life for patients with severe COPD

November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.

28 Nov 2012

Simple steps for healthy holidays and wellbeing into the New Year

The holidays are here, and weight gain is on everyone's mind. Being skinny, however, doesn't equate to being healthy, according to a video by Connie Gee, vice president and employee wellness strategist for Med-Vision.

28 Nov 2012

Abdominal and visceral fat detrimental to bone strength in obese men

Visceral, or deep belly, obesity is a risk factor for bone loss and decreased bone strength in men, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2012

African-American patients with CAD have low thoracic fat volume than Caucasians

While obesity is considered a cardiovascular risk factor, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) showed that African-American patients with coronary artery disease (CAD) have much less fat around their hearts compared to Caucasian patients.

28 Nov 2012

Young vascular systems adapt to obesity

Researchers have identified physiologic changes in the vascular systems of children that appear to be an adaptive response to obesity.

27 Nov 2012

GPs fitting more into patient consultations

GPs are fitting much more into patient consultations than they were a decade ago but the average length of the consultation has stayed the same, research led by the University of Sydney shows.

27 Nov 2012

Arginase might play a role in development of cardiovascular disease in type II diabetics

In a new study published in the scientific journal Circulation, scientists at Karolinska Institutet and Karolinska University Hospital in Sweden show that an enzyme called arginase might have a key part to play in the development of cardiovascular disease in patients who already have type II diabetes.

27 Nov 2012

Philips Healthcare, UH to showcase latest medical technology at Cleveland Medical Mart

University Hospitals (UH) and Philips Healthcare are among a group of global leaders in healthcare to showcase the latest medical technology at the new Cleveland Medical Mart & Convention Center.

From Philips Healthcare 27 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

Heart News and Research

Loyola receives $60,666 American Heart Association grant for cardiac research

'Sharing Age' campaign receives EC grant to encourage health ageing

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

IL17RC-mediated immune responses can be crucial in causing AMD

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

Digoxin for atrial fibrillation questioned

Combination of mixed amphetamine salts and topiramate shows promise for cocaine dependence

Diptheria-tetanus-pertussis vaccine: an interview with Dr. Rudi Eggers, World Health Organisation

Digoxin increases risk of death in patients with atrial fibrillation

Intramyocardial injection of organ-derived stem cells after AMI improves left ventricle function

New investigational procedure may prolong life for patients with severe COPD

Simple steps for healthy holidays and wellbeing into the New Year

Abdominal and visceral fat detrimental to bone strength in obese men

African-American patients with CAD have low thoracic fat volume than Caucasians

Young vascular systems adapt to obesity

GPs fitting more into patient consultations

Arginase might play a role in development of cardiovascular disease in type II diabetics

Philips Healthcare, UH to showcase latest medical technology at Cleveland Medical Mart

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News